Figure 2From: Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada Breakeven Analysis. PCV10 = 10-valent pneumococcal conjugate vaccine; PCV13 = 13-valent pneumococcal conjugate vaccine. Dashed line represents the percentage increase in PCV13 cost per dose over PCV10 cost per dose that could occur at various cost-effectiveness thresholds when direct effects and indirect effects are considered.Back to article page